BRIEF-Probiodrug: first results of preclinical study with pGlu3-Abeta-specific antibody mPBD-C06

* Probiodrug /Amyloid-beta (Abeta) aggregate-clearing by the

murine anti-pyroglutamate-3 Abeta IgG2a monoclonal antibody

PBD-C06 with and without a complement mutation in an Alzheimer's

mouse model

Read more